Stryker Corp (SYK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYK | ABT | BSX | ||
| Company | Stryker Corp | Abbott Laboratories | Boston Scientific Corp | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 387.19 | 115.68 | 90.65 | ||
| High | 390.37 | 117.64 | 91.72 | ||
| Low | 384.57 | 115.14 | 90.23 | ||
| Last | 390.14 | 117.26 | 91.50 | ||
| Change | +4.46 | +1.33 | +1.33 | ||
| % Change | +1.16% | +1.15% | +1.47% | ||
| Volume | 1,136,300 | 5,562,000 | 4,195,200 | ||
| 20-Day Average Volume | 1,498,835 | 5,430,480 | 6,442,265 | ||
| Previous Close | 385.68 | 115.93 | 90.17 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 374.39 | 115.99 | 87.03 | ||
| 20-Day Raw Stochastic | 82.82% | 56.00% | 98.01% | ||
| 20-Day Relative Strength | 64.76% | 54.13% | 68.42% | ||
| Weighted Alpha | +33.10 | +13.81 | +63.31 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.79% since 11/14/24 | +1.94% since 11/14/24 | +4.46% since 11/14/24 | ||
| Low | 380.21 on 11/15/24 | 114.43 on 11/15/24 | 86.01 on 11/15/24 | ||
| High | 398.20 on 11/18/24 | 117.94 on 11/18/24 | 91.72 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +6.23% since 10/21/24 | +0.23% since 10/21/24 | +3.92% since 10/21/24 | ||
| Low | 351.29 on 10/25/24 | 112.50 on 10/30/24 | 80.64 on 10/30/24 | ||
| High | 398.20 on 11/18/24 | 121.00 on 11/06/24 | 91.72 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | +12.98% since 08/21/24 | +5.27% since 08/21/24 | +16.10% since 08/21/24 | ||
| Low | 343.95 on 10/07/24 | 111.05 on 08/22/24 | 78.53 on 08/23/24 | ||
| High | 398.20 on 11/18/24 | 121.00 on 11/06/24 | 91.72 on 11/21/24 | ||
| 6-Month | |||||
| %Chg | +18.04% since 05/21/24 | +13.89% since 05/21/24 | +20.92% since 05/21/24 | ||
| Low | 314.93 on 08/05/24 | 99.71 on 07/18/24 | 71.88 on 08/05/24 | ||
| High | 398.20 on 11/18/24 | 121.00 on 11/06/24 | 91.72 on 11/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 147,027,392 | 201,075,360 | 132,894,976 | ||
| Shares Outstanding, K | 381,216 | 1,734,455 | 1,473,827 | ||
| Annual Sales | 20,498,000,000 | 40,109,000,000 | 14,240,000,000 | ||
| Annual Net Income | 3,165,000,000 | 5,723,000,000 | 1,591,000,000 | ||
| Last Quarter Sales | 5,494,000,000 | 10,635,000,000 | 4,209,000,000 | ||
| Last Quarter Net Income | 834,000,000 | 1,646,000,000 | 468,000,000 | ||
| 60-Month Beta | 0.91 | 0.72 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.87 on 10/29/24 | 1.21 on 10/16/24 | 0.63 on 10/23/24 | ||
| Latest Earnings Date | 10/29/24 | 10/16/24 | 10/23/24 | ||
| Most Recent Dividend | 0.800 on 09/30/24 | 0.550 on 10/15/24 | N/A | ||
| Next Ex-Dividends Date | 09/30/24 | 10/15/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 33.39 | 25.91 | 38.28 | ||